Clinical Trial Update: X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial of X-ray psoralen activated cancer therapy across head and neck cancer, breast cancer, sarcoma, and melanoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Cancer
• Melanoma
• Sarcoma

Drugs mentioned

• X-ray Psoralen Activated Cancer Therapy

Snippet

Sponsor: Immunolight, LLC | Conditions: Advanced Solid Tumor Cancer | Phase 1 | Status: RECRUITING